Patent · US Active

Reverse genetics using non-endogenous pol I promoters

US9072702B2 · kind B2 · utility

1Cited by

0References

20Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Philip Dormitzer · Cambridge, US
Michael Franti · Blainville, CA
Peter Mason · Somerville, US
Pirada Suphaphiphat · Cambridge, US
Bjoern Keiner · Basel, CH
Stefania Crotta · Cesano Maderno, IT

Key dates

Filing date	May 21, 2010
Grant date	Jul 7, 2015
Priority date	—
Expiry date	Jul 4, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/85
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Expression of a transgene is driven in a host cell using a pol I promoter which is not endogenous to an organism from the same taxonomic order from which the host cell is derived.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.